Simulations Plus (SLP) Partners with Large Pharmaceutical Company to Advance ADMET Predictor Machine Learning Software

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/11/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT
6. ACVA
7. SEDG
8. SPCX
9. TLT
10. PMTS

Go back to Simulations Plus (SLP) Partners with Large Pharmaceutical Company to Advance ADMET Predictor Machine Learning Software

Simulations Plus (SLP) Misses Q2 EPS by 2c, Revenues Beat

April 9, 2020 4:47 PM EDT

Simulations Plus (NASDAQ: SLP) reported Q2 EPS of $0.12, $0.02 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $10.3 million versus the consensus estimate of $9.86 million.

2QFY20 highlights compared with 2QFY19:

Net revenues increased 22.2%, or $1.9 million, to $10.3 million from $8.5 millionGross profit was $7.7 million, up $1.4 million, or 22.7%, from $6.3 millionSG&A was $4.1 million, up $1.3 million, or 46.3%, from $2.8 millionSG&A as a percentage of revenues increased to 39.7% from 33.2%, inclusive of $350,000 in transaction costs related to the Lixoft acquisitionR&D expense increased 3.3%, or $23,600, to $748,000 from $724,000Income before taxes increased 5.2%, or $140,500, to... More